- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/14 - Particulate form, e.g. powders
Patent holdings for IPC class A61K 9/14
Total number of patents in this class: 10067
10-year publication summary
|
748
|
844
|
744
|
827
|
753
|
670
|
571
|
569
|
506
|
222
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19803 |
108 |
| Board of Regents, The University of Texas System | 5745 |
61 |
| Chiesi Farmaceutici S.p.A. | 950 |
53 |
| Massachusetts Institute of Technology | 10002 |
50 |
| MannKind Corporation | 525 |
50 |
| Novartis AG | 10927 |
42 |
| The University of North Carolina at Chapel Hill | 2021 |
42 |
| Merck Patent GmbH | 5840 |
40 |
| Crititech, Inc. | 72 |
40 |
| Mayo Foundation for Medical Education and Research | 3183 |
39 |
| Modernatx, Inc. | 1258 |
36 |
| Pfizer Inc. | 3358 |
35 |
| Northwestern University | 3357 |
32 |
| BASF SE | 20758 |
31 |
| Flamel Ireland Limited | 110 |
30 |
| The Johns Hopkins University | 5637 |
29 |
| The General Hospital Corporation | 4701 |
29 |
| Abraxis BioScience, LLC | 208 |
29 |
| Evonik Operations GmbH | 4040 |
28 |
| iCeutica Pty Ltd | 38 |
26 |
| Other owners | 9237 |